Mitchell Taylor

Mr. Mitchell Taylor

University of Memphis, Memphis, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
MTMitchell Taylor
Mitchell Taylor
RWRaymond Edward Wilson
Raymond Edward Wilson
KAKristopher Daniel Amrhein
Kristopher Daniel Amrhein
Xiaohua HuangXiaohua Huang
Xiaohua Huang
Noble metal nanoparticles have been sought after in cancer nanomedicine during the past two decades, owing to the unique localized surface plasmon resonance that induces strong absorption and scattering properties of the nanoparticles. A popular application of noble metal nanoparticles is photothermal therapy, which destroys cancer cells by heat generated by laser irradiation of the nanoparticles. Gold nanorods have stood out as one of the major types of noble metal nanoparticles for photothermal therapy due to the facile tuning of their optical properties in the tissue penetrative near infrared region, strong photothermal conversion efficiency, and long blood circulation half-life after surface modification with stealthy polymers. In this review, we will summarize the optical properties of gold nanorods and their applications in photothermal therapy. We will also discuss the recent strategies to improve gold nanorod-assisted photothermal therapy through combination with chemotherapy and photodynamic therapy.

4 January 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
KAKristopher Amrhein
Kristopher Amrhein
MTMitchell Taylor
Mitchell Taylor
RWRaymond Wilson
Raymond Wilson
CGCaleb Edward Gallops
Caleb Edward Gallops
AAAssam Annamer
Assam Annamer
Xiaohua HuangXiaohua Huang
Xiaohua Huang

4 January 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
ARAlberto Luis Rodriguez-Nieves
Alberto Luis Rodriguez-Nieves
MTMitchell Taylor
Mitchell Taylor
RWRaymond Wilson
Raymond Wilson
BEBrinton King Eldridge
Brinton King Eldridge
SNSamadhi Nawalage
Samadhi Nawalage
Xiaohua HuangXiaohua Huang
Xiaohua Huang

28 January 2023 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MTMitchell Taylor
Mitchell Taylor
AGAnthony Gregory Giacalone
Anthony Gregory Giacalone
KAKristopher Daniel Amrhein
Kristopher Daniel Amrhein
RWRaymond Edward Wilson
Raymond Edward Wilson
Yongmei WangYongmei Wang
Yongmei Wang
Xiaohua HuangXiaohua Huang
Xiaohua Huang
Extracellular vesicles (EVs) have emerged as a novel resource of biomarkers for cancer and certain other diseases. Probing EVs in body fluids has become of major interest in the past decade in the development of a new-generation liquid biopsy for cancer diagnosis and monitoring. However, sensitive and specific molecular detection and analysis are challenging, due to the small size of EVs, low amount of antigens on individual EVs, and the complex biofluid matrix. Nanomaterials have been widely used in the technological development of protein and nucleic acid-based EV detection and analysis, owing to the unique structure and functional properties of materials at the nanometer scale. In this review, we summarize various nanomaterial-based analytical technologies for molecular EV detection and analysis. We discuss these technologies based on the major types of nanomaterials, including plasmonic, fluorescent, magnetic, organic, carbon-based, and certain other nanostructures. For each type of nanomaterial, functional properties are briefly described, followed by the applications of the nanomaterials for EV biomarker detection, profiling, and analysis in terms of detection mechanisms.

11 January 2024 in ACS Omega
Verified
Journal Article
Open access
CYCarey Huang Yi
Carey Huang Yi
MTMitchell Taylor
Mitchell Taylor
JZJesse Ziebarth
Jesse Ziebarth
Yongmei WangYongmei Wang
Yongmei Wang
Protein-protein interactions (PPIs) play a central role in nearly all cellular processes. The strength of the binding in a PPI is characterized by the binding affinity (BA) and is a key factor in controlling protein-protein complex formation and defining the structure-function relationship. Despite advancements in understanding protein-protein binding, much remains unknown about the interfacial region and its association with BA. New models are needed to predict BA with improved accuracy for therapeutic design. Here, we use machine learning approaches to examine how well different types of interfacial contacts can be used to predict experimentally determined BA and to reveal the impact of the specific amino acids at the binding interface on BA. We create a series of multivariate linear regression models incorporating different contact features at both residue and atomic levels and examine how different methods of identifying and characterizing these properties impact the performance of these models. Particularly, we introduce a new and simple approach to predict BA based on the quantities of specific amino acids at the protein-protein interface. We found that the numbers of specific amino acids at the protein-protein interface were correlated with BA. We show that the interfacial numbers of amino acids can be used to produce models with consistently good performance across different data sets, indicating the importance of the identities of interfacial amino acids in underlying BA. When trained on a diverse set of complexes from two benchmark data sets, the best performing BA model was generated with an explicit linear equation involving six amino acids. Tyrosine, in particular, was identified as the key amino acid in controlling BA, as it had the strongest correlation with BA and was consistently identified as the most important amino acid in feature importance studies. Glycine and serine were identified as the next two most important amino acids in predicting BA. The results from this study further our understanding of PPIs and can be used to make improved predictions of BA, giving them implications for drug design and screening in the pharmaceutical industry.

10 February 2025 in Nanomaterials
Verified
Journal Article
Open access
PDF file
ARAlberto Luis Rodriguez-Nieves
Alberto Luis Rodriguez-Nieves
SSSuprava Shah
Suprava Shah
MTMitchell Taylor
Mitchell Taylor
Alle MadhusudhanAlle Madhusudhan
Alle Madhusudhan
Xiaohua HuangXiaohua Huang
Xiaohua Huang
Nanoparticles have been widely used in cancer diagnostics and treatment research due to their unique properties. Magnetic nanoparticles are popular in imaging techniques due to their ability to alter the magnetization field around them. Plasmonic nanoparticles are mainly applied in cancer treatments like photothermal therapy due to their ability to convert light into heat. While these nanoparticles are popular among their respective fields, magnetic–plasmonic core–shell nanoparticles (MPNPs) have gained popularity in recent years due to the combined magnetic and optical properties from the core and shell. MPNPs have stood out in cancer theranostics as a multimodal platform capable of serving as a contrast agent for imaging, a guidable drug carrier, and causing cellular ablation through photothermal energy conversion. In this review, we summarize the different properties of MPNPs and the most common synthesis approaches. We particularly discuss applications of MPNPs in cancer diagnosis and treatment based on different mechanisms using the magnetic and optical properties of the particles. Lastly, we look into current challenges they face for clinical applications and future perspectives using MPNPs for cancer detection and therapy.